BECN1 and cancer: Quantitative analysis of flow cytometry demonstrated that cancer cells treated with PtMet2 and PtMet2–PAMAM markedly upregulated AMPKβ1/2 and Beclin-1 (initiation factors for autophagosome formation) as compared to the control and cisplatin (Figure 12 and Figure 13).